Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine)

Bioconjugate Chemistry

Volumn 21, Issue 2, 2010, Pages 229-239

  Hazari, Puja Panwar ^a   Shukla, Gauri ^a   Goel, Vijay ^a   Chuttani, Krishna ^a   Kumar, Nitin ^a   Sharma, Rajnish ^a   Mishra, Anil Kumar ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE DIETHYLENETRIAMINEPENTAACETIC ACID METHIONINE TECHNETIUM TC 99M; PENTETIC ACID DERIVATIVE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BRAIN TUMOR; BREAST CANCER; BREAST TUMOR; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISSOCIATION CONSTANT; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; DRUG HALF LIFE; DRUG STABILITY; DRUG SYNTHESIS; DRUG TRANSPORT; DRUG UPTAKE; FEMALE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOSARCOMA; PREDICTION; RABBIT; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

MUS;

EID: 77049109903     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc900197n     Document Type: Article

References (33)

1. Torrents, D., Estevez, R., Pineda, M., Fernandez, E., Lloberas, J., Shi, Y. B., Zorzano, A., and Palacin, M. (1998) Identification and characterization of a membrane protein (y1L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y1L: a candidate gene for lysinuric protein intolerance. J. Biol. Chem. 273, 32437-32445.
2. Verrey, F. (2003) System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch. 445, 529-533.
3. Lahoutte, T., Caveliers, V., Camargo, S. M., Franca, R., Ramadan, T., Veljkovic, E., Mertens, J., Bossuyt, A., and Verrey, F. (2004) SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation. J. Nucl. Med. 45, 1591-1596.
4. Campbell, W. A., and Thompson, N. L. (2001) Overexpression of LAT1/CD98 light chain is sufficient to increase system L-amino acid transport activity in mouse hepatocytes but not fibroblasts. J. Biol. Chem. 276, 16877-16884.
5. Bodoy, S., Martín, L., Zorzano, A., Palacín, M., Estévez, R., and Bertran, J. (2005) Identification of LAT4, a novel amino acid transporter with system L activity. J. Biol. Chem. 280, 12002-12011.
6. Kim, D. K., Kim, I.J., Hwang, S., Kook, J. H., Lee, M. C., Shin, B. A., Bae, C. S., Yoon, J. H., Ahn, S. G., Kim, S. A., Kanai, Y., Endou, H., and Kim, J. K. (2004) System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells. Neurosci. Res. 50, 437-446.
7. Fuchs, B. C., and Bode, B. P. (2005) Amino acid transporters ASCT2 and LAT1in cancer: partners in crime. Semin. Cancer. Biol. 15, 254-266.
8. Ogawa, T., Miura, S., Murakami, M., Tida, H., Hatazawa, J., Inugami, A., Kanno, I., Yasui, N., Sasajima, T., and Uemura, K. (1996) Quantitative evaluation of neutral amino acid transport in cerebral gliomas using positron emission tomography and fluorine-18 fluorophenylalanine. Eur. J. Nucl. Med. 23, 889-895.
9. Wienhard, K., Herholz, K., Coenen, H. H., Rudolf, J., Kling, P., Stöcklin, G., and Heiss, W. D. (1991) Increased amino acid transport into brain tumors measured by PETof L-(2Y18F)fluorotyrosine. J. Nucl. Med. 32, 1338-1346.
10. Wester, H. J., Herz, M., Weber, W., Heiss, P., Senekowitsch- Schmidtke, R., Schwaiger, M., and Stöcklin, G. (1999) Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J. Nucl. Med. 40, 205-212.
11. 11C]methionine uptake in brain tumours: initial results of a comparative study. Eur. J. Nucl. Med. 27, 542-549.
12. Dirk, P., Gabriele, S., Winfried, S., Kurt, H., Dagmar, B., Lutz, T., Hans, H., Stefan, B., Heinz, H. C., and Karl, J. L. (2005) PET with O-(2-18FFluoroethyl)-L-tyrosine in peripheral tumors: first clinical results. J. Nucl. Med. 46, 411-416.
13. Pieter, L. J., Willem, V., Jan, P., Elisabeth, G. E., de Vries, K. J., Langen, and Albertus, P. (2001) Radiolabeled amino acids: basic aspects and clinical applications in oncology. J. Nucl. Med. 42, 432-445.
14. Stern, P. H., Wallace, C. D., and Hoffman, R. M. (1984) Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J. Cell Physiol. 119, 29-34.
15. Tisdale, M. (1980) Effect of methionine deprivation on methylation and synthesis of macromolecules. Br. J. Cancer 42, 121-128.
16. Kreis, W., and Goodenow, M. (1978) Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. Cancer Res. 38, 2259-2262.
17. Mecham, J., Rowitch, D., Wallace, C. D., Stern, P. H., and Hoffman, R. M. (1983) The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem. Biophys. Res. Commun. 117, 429-434.
18. Hoffman, R. M. (1985) Altered methionine metabolism and transmethylation in cancer. Anticancer Res. 5, 1-30.
19. Judde, J. G., Ellis, M., and Frost, P. (1989) Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Res. 49, 4859-4865.
20. Isselbacher, K. J. (1972) Increased uptake of amino acids and 2-deoxy-2-glucose by virus-transformed cells in culture. Proc. Natl. Acad. Sci. U.S.A. 69, 585-589.
21. Miyagawa, T., Oku, T., and Uehara, H. (1998) Facilitated amino acid transport is upregulated in brain tumors. J. Cereb. Blood Flow Metab. 18, 500-509.
22. 18F-FDG PET. Eur. J. Nucl. Med. Mol. Imaging 29, 176-218
23. 11C-L-Methionine positron emission tomography in the clinical management of cerebral gliomas. Mol. Imaging Biol. 10, 1-18.
24. 11C]- lmethionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur. J. Nucl. Med. Mol. Imaging 30, 868-873.
25. 11C-Methionine PET for differential diagnosis of low-grade gliomas. Neurology 50, 1316-1322.
26. Ali, M. S., and Quadri, S. M. (1996) Maleimido derivatives of diethylenetriaminepentaacetic acid and triethylenetetraaminehexaacetic acid: their synthesis and potential for specific conjugation with biomolecules. Bioconjugate Chem. 7 (5), 576-583
27. Fu, Y., Laurent, S., and Muller, R. N. (2002) Synthesis of a silyl lewis mimetic conjugated with DTPA, potential ligand of new contrast agents for medical. Imaging Eur. J. Org. Chem. 23, 3966-3973.
28. Panwar, P., Iznaga, E. N., Mishra, P., Shrivastava, V., Sharma, R. K., Chandra, R., and Mishra, A. K. (2005) Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy. Cancer Biol. Ther. 4 (8), 854-860.
29. 99mTc-based folatederivative for the detection of folate receptor positive tumors: synthesis and biological evaluation. Cancer Biol. Ther. 3 (10), 995-1001.
30. Mishra, A. K., Panwar, P., Hosono, M., Chuttani, K., Mishra, P., Sharma, R. K., and Chatal, J. F. (2004) A new bifunctional chelating agent conjugated with monoclonal antibody and labelled with technetium-99m for targeted scintigraphy: 6-(4-isothiocyanatobenzyl)-5,7-dioxo-1,11-(carboxymethyl)- 1,4,8,11-tetraazacyclotridecane. J. Drug Targeting 12 (9-10), 556-559.
31. Mishra, A. K., Panwar, P., Chopra, M., Sharma, R. K., and Chatal, J. F. (2003) Synthesis of novel bifunctional schiff based ligands derived from condensation of 1-(p-nitrobenzyl) ethylenediamine and 2-(-nitrobenzyl)-3- monooxo-1, 4,7-triazaheptane with salicylaldehyde. New J. Chem. 27, 1054-1058.
32. 99mTc-methionine scintimammography in the evaluation of breast cancer. Nuc. Med. Commun. 12 (1), 22-25.
33. Keiichi, K., Ohnishi, P. A., Shimizu, J., Kanai, S., Shiokawa, Yoshiaki, Y., and Motoo, N. (2008) Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells. Neurosurgery 62 (2), 493-504.